| Date | Form | Description | Docs | XBRL | Pages |
| 10/24/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/21/16 | 8-K | Current report filing |
|
3 | |
| 10/18/16 | 8-K | Current report filing |
|
4 | |
| 09/07/16 | 3/A | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/01/16 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/01/16 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 08/26/16 | 8-K | Current report filing |
|
3 | |
| 08/26/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 07/05/16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...